Demand for dexamethasone rises after study finds COVID-19 benefits, FDA data shows
The steroid dexamethasone, shown to reduce COVID-19 deaths, was in shortage before the pandemic and has gotten more scarce.
Demand for dexamethasone rises after study finds COVID-19 benefits, FDA data shows
USATODAY.com
0 shares
1 views
You might like
Related news coverage
'One-sided relationship': Food suppliers feeling pinched as grocers hike fees
Walmart’s plan to charge its suppliers extra fees appears to have reinvigorated a long-simmering battle between supermarkets and..
Financial Post
NA Proactive news snapshot: Ipsidy, Avalon GloboCare, BioSig Technologies, Co-Diagnostics, Black Iron, Thunderbird Entertainment UPDATE …
Ipsidy Inc (OTCQB:IDTY) announced Monday that it has expanded its Proof and Verified Identity-as-a-Services solutions to be..
Proactive Investors